Latest news

• 19 February 2019

  Helsinn Investment Fund Invests €1 Million in Gain Therapeutics

  Luxembourg, February 19, 2019: Helsinn Investment Fund S.A,...
• 14 February 2019

  Helsinn and MEI Pharma Announce Publication of Phase II Data for Pracinostat in Combination with Azacitidine in the Frontline Treatment of Older AML Patients Unfit for Intensive Chemotherapy, in Blood Advances

  Lugano, Switzerland and San Diego, USA, February...
• 31 January 2019

  Helsinn Provides Educational Grant for ESMO’s Preceptorship for Supportive and Palliative Care

  Lugano, Switzerland, January 31, 2019 – Helsinn, a Swiss...